Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer.
about
Tumor-Infiltrating Immune Cells Are Associated With Prognosis of Gastric Cancer.Potential therapeutic strategy for gastric cancer peritoneal metastasis by NKG2D ligands-specific T cellsClinical significance of tumor expression of major histocompatibility complex class I-related chains A and B (MICA/B) in gastric cancer patients.Exploiting natural killer group 2D receptors for CAR T-cell therapy.Upregulation of thioredoxin-1 in activated human NK cells confers increased tolerance to oxidative stress.A New Ex Vivo Method for Effective Expansion and Activation of Human Natural Killer Cells for Anti-Tumor Immunotherapy.Low-dose gemcitabine induces major histocompatibility complex class I-related chain A/B expression and enhances an antitumor innate immune response in pancreatic cancer.Oxaliplatin regulates expression of stress ligands in ovarian cancer cells and modulates their susceptibility to natural killer cell-mediated cytotoxicity.NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival.Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: a meta-analysis.The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma.Augmentation of antibody-dependent cellular cytotoxicity with defucosylated monoclonal antibodies in patients with GI-tract cancer.Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility.Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer
P2860
Q36195996-FD6E330B-B7D2-4C31-972B-74049B666BCEQ36212699-4B3EBE29-0382-4735-A756-2A4B212CB293Q36572148-9EEE7D6F-F5C9-4992-ADEB-E98B16B34BA7Q38671184-BA9D67F0-C3A1-4716-B040-A7FCCA01D87EQ38715422-BA882A9F-2631-4EAD-8C2E-4E76E508B5ACQ38766781-DE05E117-2E96-4BF1-85D8-2F802B3AD280Q38829403-7C96E301-A9C3-4C77-B9CE-4B4663E9BF00Q38857163-9DD9D4A1-A3E1-4476-92E8-02AD55FF521CQ38941698-986B01DF-2859-43E7-AE65-2C57DA5D1AEBQ41341715-0DAFA78F-F3C8-4EA9-8C6D-7071C27083C9Q42700830-420E666D-587A-4A7A-97BD-FA3B8442781EQ50053443-3E4BDA20-8D70-42D5-B21B-B33E962D60DCQ53140686-519E7393-8307-41F4-AEAA-CCC98F755790Q57167306-70C86F79-EA89-4DF1-8E4E-E1B65E00BF96
P2860
Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer.
@en
Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer.
@nl
type
label
Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer.
@en
Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer.
@nl
prefLabel
Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer.
@en
Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer.
@nl
P2093
P2860
P356
P1476
Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer.
@en
P2093
Dario Campana
Hideki Fujii
Kensuke Shiraishi
Kousaku Mimura
Ley-Fang Kua
Takahiro Kamiya
Takashi Nakano
Wei-Peng Yong
Yoshiyuki Suzuki
P2860
P304
P356
10.1002/IJC.28780
P577
2014-02-28T00:00:00Z